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Background/aim: Studies have shown an increased depression rate in patients with type 2 diabetes mellitus (T2DM) compared to the
normal population. It is now acknowledged that patients suffer from distress rather than depression. Our aim was to validate the Turkish
version of the Diabetes Distress Scale (DDS) and to show distress levels of the participants.
Materials and methods: The scale was translated from English to Turkish by the authors and translated back to English. Between
August 2015 and January 2016 all the patients who were referred to the T2DM Clinic of İstanbul Medeniyet University were screened,
and eligible patients were recruited. For calculating internal consistency Cronbach’s alpha coefficient was used.
Results: A total of 205 patients [120 females (58.5%), 85 males (41.5%)] were included. Cronbach’s alpha coefficient was 0.874, showing
internal consistency. The Spearman Brown correlation coefficient was calculated between the first 9 and second 8 questions as 0.884.
Thetotal variances were explained at a level of 66.2% with 4 factors. Sixty-three patients (30%) had a score of ≥3, indicating diabetic
distress. Correlation analysis showed a significant correlation between total score and HbA1c levels (r = 0.152 and P = 0.038).
Conclusion: The Turkish version of the DDS for type 2 diabetes is a reliable tool for assessment of distress levels.
Key words: Diabetes Distress Scale, Turkish, validation, type 2 diabetes

1. Introduction
Type 2 diabetes mellitus (T2DM) is a growing epidemic
and it is projected that by 2035 almost 600 million people
in the world will have the disease [1]. This increase in
T2DM prevalence has made T2DM one of the major health
issues of the world in the last decade. From cardiovascular
diseases to end-stage kidney disease, T2DM causes
morbidity and mortality second to none [2].
In recent years, along with metabolic complications,
psychological damage caused by T2DM diagnosis has
also been investigated [3]. Studies have shown increased
depression rates in patients with T2DM compared to the
normal population [4] and an increased mortality risk is
also associated with depression in patients with T2DM [5].
Although depression should still be suspected in patients
with prominent symptoms, it is now acknowledged that
patients suffer from T2DM-associated distress rather than
depression [6,7]. Major depressive disorder is diagnosed
with the presence of at least 5 of the 9 symptoms that persist
for at least 2 weeks [8]. It is not diagnosed according to a

specific etiology. However, distress consists of the worries,
concerns, and fears of individuals and it has a broader
spectrum of feelings [7]. Three-dimensional study has
shown that 84% of patients with moderate-high distress
did not reach a diagnosis of major depressive disorder [9].
Patients with diabetes and positive depression scores do
not always have the symptoms of major depressive disorder
to reach a diagnosis [10]. Within this context, a more
target-specific tool is needed to assess distress of patients
with diabetes. Otherwise, patients would be misdiagnosed
with depression and treated pharmacologically although
all they suffer from is diabetes-related anxiety.
The Diabetes Distress Scale (DDS) was created by
Polonsky et al. [11] to diagnose T2DM-associated distress.
It is a 17-item psychological measurement tool that uses a
Likert scale with each item scored from 1 (no distress) to
6 (serious distress) to reflect distress experienced over the
last month. The DDS examines patients’ distress regarding
their treatment, overall life style behavior, social support,
and relationship with healthcare providers. There are four
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sources of distress identified by the scale: regimen distress,
emotional burden, interpersonal distress, and physician
distress. This study aims to validate the Turkish version of
the DDS and assess the DDS scores of patients with T2DM.
2. Material and methods
2.1. Ethics
Ethical approval for the study was obtained from the
İstanbul Medeniyet University Ethics Committee (Date:
07.29.2015, Decision Number: 2015/0107). Patients were
given consent forms to sign and the rules of the Helsinki
Declaration were followed throughout the study.
2.2. Permission
Permission to use and translate the scale was obtained
from the creator of the scale, William Polonsky, via email.
The Turkish version of the scale was also shared with the
author.
2.3. Translation
The scale was translated from English to Turkish by the
authors (ÖTÇ, AO, ND) and then retranslated (backtranslation) to English by the Head of the Foreign
Languages Department of İstanbul Medeniyet University.
Three internists evaluated and gave scores to assess the
context validity of the translation.
2.4. Sample size calculation
For validation studies, the general approach is to recruit
5–10 subjects for each question that the scale possesses
[12]. A 20% loss was presumed and 205 patients were
included.
2.5. Participants
Between August 2015 and January 2016 all the patients
who were referred to the T2DM Clinic of İstanbul
Medeniyet University’s Department of Internal Medicine
were screened. Patients were included in the study if they
had a T2DM diagnosis and gave consent to participate
in the study. Exclusion criteria were being ≤18 years old,
having type 1 diabetes, presence of a psychological disease,
presence of a morbidity that can affect life quality (cancer,
chronic kidney disease etc.), being pregnant, and not
having sufficient intellectual capacity to understand the
questions of the scale. The DDS was applied to illiterate
patients with the help of their relatives.
Patients’ demographic characteristics including age,
sex, T2DM duration, educational status, medications,
body mass index (BMI), waist circumference, and
metabolic parameters (fasting glucose level, HbA1c, etc.)
were recorded. There were no newly diagnosed drug-naive
patients, the mean duration of diabetes was 10.7 years, and
56.9% of the patients (n = 116) were on insulin treatment.
2.6. Assessment of distress
The DDS is a 17-item psychological measurement tool that
uses a Likert scale with each item scored from 1 (no distress)

to 6 (serious distress) to reflect distress experienced over
the last month. The total score is calculated by dividing
the sum of the answers by 17. A score of ≥3 is defined
as T2DM-related distress. There are four subscales and
subscale scores are also calculated by dividing the sum
of subscale answers to the total question count of the
subscale. Subscales are as follows: the emotional burden
subscale with 5 questions, the physician-related distress
subscale with 4 questions, the regimen-related distress
subscale with 5 questions, and the interpersonal distress
subscale with 3 questions. The Turkish translation of the
scale can be found at http://behavioraldiabetes.org/scalesand-measures/ and in Table 1.
2.7. Statistical analysis
In addition to the descriptive statistical methods (mean,
standard deviation, median, frequency, percentage,
minimum, and maximum) for comparison of the
quantitative data, the Student t-test was used for twogroup comparisons of the variables with normal
distribution and the Mann–Whitney U test was used for
two-group comparisons of the variables with nonnormal
distribution. One-way ANOVA was used to compare three
or more groups for variables with normal distribution
and the Kruskal–Wallis test was used to compare three
or more groups with nonnormal distribution. Pearson
correlation and Spearman correlation coefficients were
used to evaluate the relationships between the variables.
Significance level was set at P < 0.01 and P < 0.05.
Cronbach’s alpha was calculated to check for internal
consistency of the scale. The split-half method with
Spearman Brown correlation coefficient was used to assess
intraclass consistency. Exploratory factor analysis was
used to evaluate the construct validity of the questionnaire.
Before factor analysis, some preliminary tests were used.
The Kaiser–Meyer–Olkin (KMO) test was used to assess
efficiency of the sample size. The Bartlett test of sphericity
was used to evaluate whether the diagonal terms of the
correlation matrix were 1 and the nondiagonal terms
were 0. Principal component analysis was used to reveal
the structure of factors. A rotation component matrix
was used to determine the factor structures. Factors were
determined by grouping the questions according to those
with high weights on factors. Analyses were performed
with SPSS 21 (IBM Corp., USA).
3. Results
A total of 205 patients [120 females (58.5%), 85 males
(41.5%)] were included. Demographic features of the
patients are listed in Table 2.
Cronbach’s alpha coefficient was found to be 0.874,
showing internal consistency. The Spearman Brown
correlation coefficient was calculated between the first
9 and second 8 questions as 0.884. This result shows
that the intraclass consistency of the questionnaire was
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Table 1. Turkish version of Diabetes Distress Scale.

Sorunlar

Sorun
değil

Hafif bir
sorun

Orta
düzeyde
sorun

Aslında ciddi
olabilecek bir
sorun

Ciddi
sorun

Çok ciddi
sorun

1. Diyabetin her gün zihinsel ve fiziksel enerjimi çok fazla
aldığını hissediyorum.

1

2

3

4

5

6

2. Doktorumun diyabet ve diyabet bakımı konusunda yeterli
bilgiye sahip olmadığını hissediyorum.

1

2

3

4

5

6

3. Diyabet ile yaşamı düşündüğüm zaman kızgın, endişeli ve /
veya depresif hissediyorum.

1

2

3

4

5

6

4. Doktorumun diyabetimi yönetmede beni yeterince açık
yönlendirmediğini hissediyorum.

1

2

3

4

5

6

5. Kan şekeri takibimi yeterli sıklıkta yapmadığımı
hissediyorum.

1

2

3

4

5

6

6. Diyabet rutinimde sıklıkla başarısız olduğumu
hissediyorum.

1

2

3

4

5

6

7. Arkadaşlarımın veya ailemin öz - bakım çalışmalarımı
yeterince desteklemediğini hissediyorum.
(örneğin: ‘yanlış’ yiyecekler yemem için teşvik etmeleri,
planladıkları aktivitelerin benim programımla uyuşmaması)

1

2

3

4

5

6

8. Diyabetin hayatımı kontrol ettiğini hissediyorum.

1

2

3

4

5

6

9. Doktorumun endişelerimi yeterince ciddiye almadığını
hissediyorum.

1

2

3

4

5

6

10. Diyabetimi gün be gün yönetebileceğimden emin
hissetmiyorum.

1

2

3

4

5

6

11. Ne yaparsam yapayım sonunda ciddi uzun dönem
komplikasyonların olacağını hissediyorum.

1

2

3

4

5

6

12. İyi bir yeme planına yeteri kadar bağlanmadığımı
hissediyorum.

1

2

3

4

5

6

13. Arkadaşlarım ve ailemin diyabetle yaşayabilmenin ne kadar
1
zor olduğunu anlamadığını hissediyorum.

2

3

4

5

6

14. Diyabetle yaşamın gerektirdiklerinden bunalmış
hissediyorum.

1

2

3

4

5

6

15. Diyabetim için düzenli olarak görüşebileceğim bir doktora
1
sahip olmadığımı hissediyorum.

2

3

4

5

6

16. Kendi diyabet takibimi yapabilecek kadar motivasyon
hissetmiyorum.

1

2

3

4

5

6

17. Arkadaşlarımın ve ailemin istediğim duygusal desteği
verdiğini hissetmiyorum.

1

2

3

4

5

6

Not: Diyabet yerine şeker hastalığı tanımı da kullanılabilir.

good. Exploratory factor analysis was used to evaluate
the construct validity of the questionnaire. The KMO
parameter was calculated as 0.853. This result shows that
the sample size was appropriate for factor analysis. The
Bartlett test of sphericity was used to evaluate whether
the diagonal terms of the correlation matrix were 1 and
the nondiagonal terms were 0. In our study, we cannot
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reject the null hypothesis (population correlation matrix
is an identity matrix) (P < 0.001). The diagonal terms of
the antiimage correlation matrix vary from 0.792 to 0.932.
Principal component analysis was used to reveal the
structure of factors. Explained total variances are shown
in Table 3. The total variances were explained at a level of
66.2% with 4 factors.
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Table 2. Demographic characteristics of the cohort.
Variables

Patients (n = 205)

Age (years)

55.29 ± 10

Diabetes duration (years)

10.7 ± 6.8

Waist circumference (cm)

Males: 103 ± 12
Females: 108 ± 12

Body mass index (kg/m2 )

32.2 ± 12

Fasting plasma glucose (mg/dL)

184 ± 89

Hemoglobin A1c (%)

8.5 ± 2.2

Creatinine (mg/dL)

0.8 ± 0.2
			N
Illiterate			
22
Elementary school		
104
Middle school		
18
High school		 32
University		 29

Education status

%
10.7
50.7
8.8
15.6
14.1

Table 3. Explained total variance.
Factor

Eigenvalues

Rotation sums of squared loadings

Total

Variance %

Cumulative %

Total

Variance %

Cumulative %

1

5.741

33.772

33.772

3.505

20.616

20.616

2

2.303

13.545

47.316

2.909

17.114

37.730

3

1.916

11.273

58.589

2.491

14.654

52.383

4

1.287

7.571

66.161

2.342

13.778

66.161

5

0.806

4.744

70.904

6

0.674

3.964

74.868

7

0.621

3.651

78.520

8

0.552

3.245

81.764

9

0.527

3.102

84.866

10

0.470

2.764

87.630

11

0.450

2.646

90.276

12

0.357

2.102

92.378

13

0.314

1.849

94.226

14

0.284

1.670

95.896

15

0.274

1.611

97.507

16

0.231

1.361

98.868

17

0.192

1.132

100.000

A rotation component matrix was used to determine
the factor structures (Table 4). Factors were determined
by grouping the questions with high weights on factors.
In our study, weights of ≥0.48 were thought of as sufficient
to include as a factor. Those factors were developed like
the original scale. None of the names of the factors were

revised. The only difference between the original scale and
the validated scale was the 16th question, which was seen
for factor 1.
Mean diabetes duration of the population was 10.2
± 6.9 years and 57.1% of the patients were on insulin
treatment. Table 2 shows patients’ education statuses.
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Table 4. Rotational factor matrix.
Factor

Question 1
Question 2
Question 3
Question 4
Question 5
Question 6
Question 7
Question 8
Question 9
Question 10
Question 11
Question 12
Question 13
Question 14
Question 15
Question 16
Question 17

1

2

3

4

0.710
0.096
0.752
0.152
0.031
0.269
0.138
0.655
0.092
0.676
0.616
0.326
0.171
0.790
0.146
0.482
0.155

0.152
0.873
0.082
0.875
0.003
0.120
0.093
0.087
0.870
0.033
0.115
0.065
0.045
0.080
0.667
0.279
0.123

0.019
0.034
0.065
0.104
0.094
0.062
0.869
0.228
0.145
0.082
0.112
0.043
0.877
0.206
0.005
0.224
0.867

–0.024
0.004
0.072
0.046
0.771
0.787
0.026
0.270
–0.028
0.422
0.284
0.686
0.058
0.121
0.341
0.394
0.166

The mean total score of the patients was 2.5 ± 0.9. Sixtythree patients (30%) had a score of ≥3, indicating diabetic
distress. Female patients had higher total scores than
male patients (P = 0.002). They also had higher scores
in the emotional burden, regimen-related distress, and
interpersonal distress subscales (P = 0.003, P = 0.01, and P
= 0.004, respectively). A significant difference in total score
and scores of ≥3 was observed between patients who used
insulin and who did not (P = 0.01 and 0.02, respectively),
with higher scores in the insulin group (Table 5). There
was a statistically significant difference between patients
with HbA1c levels of ≥9 (75 mmol/mol) and <7 (53 mmol/
mol) in total distress and the emotional burden subscale,
both being higher in the high HbA1c group (P=0.02 and
P=0.01, respectively).
Correlation analysis showed that there was a significant
correlation between total score and HbA1c levels (r = 0.152
and P = 0.038), and also between the emotional burden
distress subscale and BMI (r = 0.166 and P = 0.01).
4. Discussion
In this study reliability and validation analysis of the
Turkish DDS was performed. The analysis showed good
consistency within scale questions. Also, intraclass
consistency was observed. Compatible with the original
scale, our study also showed four factors. The sixteenth
question of the scale was under the subgroup of “treatmentrelated distress” in original scale whereas, it was found in
the “emotional burden” subscale of our study. Similarly, in
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the validation analysis of the Norwegian translation of the
scale, the 11th question was found in “treatment-related
distress” instead of “emotional burden-associated distress”
[13]. These differences are often a result of cultural
variances and therefore these differences underline the
need for a validation analysis of the assessment of scale
questions.
Another important issue to consider is the population
the scale is applied to. In our study population, half of the
patients were elementary school graduates and 10% of the
subjects were illiterate. The Turkish population between
50 and 60 years is 5% illiterate and 60% of the individuals
are elementary school graduates according to 2014 data of
the Turkish Statistical Institute (www.tuik.gov.tr), which
is similar to our cohort. Therefore, it can be said that our
cohort represents the Turkish population.
Erkin et al. translated the DDS to Turkish and found
it valid and reliable [14]. However, they included patients
with type 1 diabetes although there is a different distress
scale for these patients [15]. The distress of patients with
type 1 diabetes has a different aspect. Although the DDS
for type 2 diabetes has four major categories (regimes
distress, emotional burden, interpersonal distress, and
physician distress), the DDS for type 1 diabetes has
seven. These include powerlessness, eating distress,
management distress, hypoglycemia distress, negative
social perceptions, physician distress, and friend/family
distress. There are some overlapping items, but eating
distress and hypoglycemia distress significantly differ from
the concerns of patients with T2DM. It is also reported
that distress levels are higher in younger patients with
type 1 diabetes, a finding we did not see in our cohort with
T2DM. Inclusion of patients with type 1 diabetes would
also alter mean BMI, waist circumference, and age values,
disturbing the overall analysis. Moreover, compared to the
work of Erkin et al., our study was conducted with a larger
population.
Glycemic control is an important factor that triggers
stress in patients with T2DM [16]. Patients with increased
distress also have high HbA1c levels. Similarly, this
association was observed in our correlation analysis. The
link between glycemic control and psychological health
has a bidirectional pathway [17,18]. It is a vicious cycle to
break, but some reports were published with promising
results investigating treatment modalities to improve
glycemic control by reducing distress [19].
Another factor that has been observed is the emotional
burden that BMI has for these patients. Physical appearance
has always been an important factor of psychological
well-being [20]. Thus, it is no surprise that high BMI was
correlated with increased distress levels of the patients,
especially on an emotional level. Studies have shown that
people sometimes rank themselves in society according
to their weight. In the modern world, obesity is not only
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Table 5. Comparison of patients on insulin with patients on oral antidiabetics.
Insulin users

Non-insulin users

P-value

Age

55.59 ± 10.81

54.67 ± 9.66

0.53

Duration

12.75 ± 7.19

8.07 ± 5.44

<0.00

Waist

106.93 ± 12.71

104.86 ± 12.51

0.24

Length

161.55 ± 11.90

163.38 ± 9.49

0.24

Weight

83.61 ± 16.02

84.80 ± 14.96

0.59

Glucose

203.84 ± 98.94

176.89 ± 109.11

0.04

Urea

31.12 ± 10.51

30.34 ± 9.81

0.61

Creatinine

0.83 ± 0.21

0.82 ± 0.16

0.72

Cholesterol

196.51 ± 48.77

198.20 ± 40.38

0.85

Triglyceride

189.95 ± 126.53

223.69 ± 159.69

0.36

HDL

43.02 ± 14.54

40.84 ± 11.19

0.38

LDL

120.70 ± 39.63

119.27 ± 30.63

0.84

HbA1c

9.44 ± 2.98

7.95 ± 2.12

0.003

Emotional

3.56 ± 1.37

2.86 ± 1.39

0.009

Physician

1.89 ± 1.23

1.59 ± 1.07

0.10

Regimen

2.90 ± 1.26

2.77 ± 1.22

0.54

Interpersonal

2.26 ± 1.70

2.02 ± 1.50

0.38

Sum

2.74 ± 0.99

2.39 ± 1.00

0.01

a major somatic health burden; it is also a psychological
cause of distress [21]. Females have always been affected by
body changes more than men [22], and our study results
show that women have higher distress levels than men.
This difference may be attributed to the aforementioned
appearance-related issues.
Insulin treatment is often an inconvenient choice for
patients [23]. Patients who start insulin treatment often
have side problems like visual limitations or multidrug
use, and along with these issues injection fears and the
strict rules of the treatment (punctual injection time,
dose adherence with glucose monitoring, cold-chain
transportation, etc.) create patients’ reluctance. In our
study, patients who were on insulin treatment showed
more distress than patients who were not. It is fair to say
that initiation of insulin is another factor for distress,
which can increase the discomfort patients already feel

about the disease. As expected, patients receiving insulin
treatment had longer disease duration and poor glycemic
control compared to patients not on insulin.
In conclusion, the Turkish version of the DDS for
T2DM is a reliable tool for assessment of distress levels
in this population. This study shows that distress is
linked to insulin use, high HbA1c levels, and high BMI,
suggesting a solid interaction between poor glycemic
control and psychological health. This underlines the fact
that treatment of T2DM with weight loss is the best way to
lessen the psychological discomfort patients have.
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